articles about antimicrobial

MIDA participated in an international symposium supported by South Korea, the World Bank, and OPS to coordinate efforts across the agricultural, human, and environmental sectors.

The 5-year plan aims to reduce antibiotic usage and resistance in humans and livestock and protect public health.

EFSA’s yearly report shows continued high compliance with official limits in 2024.

Sales of medically important antimicrobial drugs approved for use in food-producing animals increased by 16% between 2023 and 2024.

The latest ESUAvet report shows a 5% rise in antimicrobial sales for food-producing animals in 2024, signaling a potential shift in long-term declines.

The limit values ​​are now lowered by 20% for weaning pigs and slaughter pigs.

This year’s theme underscores the urgent need for bold, coordinated, cross-sectoral action to address AMR.

During the 30th Seminar on Harmonization of Veterinary Drug Registration and Control, Mexico assumed the presidency of CAMEVET for two years.

In 2024, there was a slight increase in antibiotic use in the UK pig sector.

€253 million for research and innovation against antimicrobial resistance.

There was a highly significant effect of PRRS health status on the median antibiotic consumption at the herd level.

The European Commission considers the Spanish system for controlling the veterinary use of antibiotics and its contribution against resistances to be adequate and effective.

A decade ago, Spain was among the countries with the highest consumption of antimicrobials in Europe, however, a voluntary initiative to reduce the use of colistin in the pig sector managed to reverse this trend and position the country as a benchmark in the responsible use of these drugs.

For the first time, all the 27 countries of the European Union together with Iceland and Norway have collected and reported data on both sales and use of antimicrobials in animals in their countries.